Results 131 to 140 of about 6,506,258 (188)

Spleens With Disseminated Lymphoma Exhibit Higher Standardized Uptake Value Maximum, Metabolic Tumor Volumes, and Total Lesion Glycolysis on Fluorine‐18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

open access: yesVeterinary Radiology &Ultrasound, Volume 67, Issue 6, November 2026.
ABSTRACT Standardized uptake value maximum (SUVmax), metabolic tumor volumes (MTV), and total lesion glycolysis (TLG) are metabolic parameters used to quantify tumors detected on fluorine‐18 fluorodeoxyglucose positron emission tomography/computed tomography (18F‐FDG PET/CT).
Jesse Johnson   +3 more
wiley   +1 more source

NVP-BEZ235 alone and in combination in mantle cell lymphoma: an effective therapeutic strategy

open access: yes, 2012
Mantle cell lymphoma (MCL) is a distinct subtype of B-cell lymphoma; the complete response rate for standard therapies in use today is 85 - 90%. NVP-BEZ235 inhibits the PI3K/Akt/mTOR signaling axis at the level of both PI3K and mTOR.
COSENZA, Maria   +4 more
core   +1 more source

An Australian Narrative Review of Adoptive Cellular Therapies in Malignancy: Expanding Indications, Referral Pathways and Safety Beyond Specialist Centres

open access: yesMedical Journal of Australia, Volume 224, Issue 11, November 2026.
ABSTRACT Adoptive cellular therapies (ACT), including tumour‐infiltrating lymphocyte (TIL), T‐cell receptor‐engineered T (TCR‐T) cell and chimeric antigen receptor T‐cell (CAR‐T) therapies, represent an evolving class of immunotherapies with established efficacy in selected haematological malignancies and emerging applications in solid tumours ...
Sarah Childs   +15 more
wiley   +1 more source

Infections and their determinants in patients with non‐Hodgkin lymphoma receiving bispecific T‐cell antibodies: Results from an international multicenter cohort study

open access: yes
HemaSphere, Volume 10, Issue 11, November 2026.
Zainab Shahid   +17 more
wiley   +1 more source

Early Integration of CAR T‐Cell Therapy in Mantle Cell Lymphoma: Expert Opinion in the Era of BTK Inhibitors

open access: yes
Hematological Oncology, Volume 44, Issue 6, November 2026.
Carlo Visco   +4 more
wiley   +1 more source

Mantle cell lymphoma presenting as solitary polypoid colonic lesions

open access: yes, 2001
Mantle cell lymphoma of the intestine is rare, usually presenting as multiple small polyps. We report three men with colonic mantle cell lymphoma in the form of single large polypoid mass.
Hussainy, A S   +3 more
core  

Central Nervous System Involvement in Mantle Cell Lymphoma: Clinical Features, Prognostic Factors and Outcomes From the European Mantle Cell Lymphoma Network

open access: yesAnnals of Oncology, 2013
Central nervous system (CNS) involvement in mantle cell lymphoma (MCL) is uncommon, and the manifestations and natural history are not well described.We present the data on 57 patients with MCL who developed CNS involvement, from a database of 1396 ...
Pavel Klener   +2 more
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Mantle-Cell Lymphoma

New England Journal of Medicine, 2022
James O, Armitage, Dan L, Longo
exaly   +5 more sources

Mantle cell lymphoma

Best Practice & Research Clinical Haematology, 2012
MCL is a well-characterized clinically aggressive lymphoma with a poor prognosis. Recent research findings have slightly improved the outcome of this neoplasm. The addition of rituximab to conventional chemotherapy has increased overall response rates, but it does not improve overall survival with respect to chemotherapy alone.
Cortelazzo S   +3 more
openaire   +5 more sources

Home - About - Disclaimer - Privacy